Acceptance of short course artesunate plus mefloquine drug combination by malaria patients in rural Myanmar.
Southeast Asian J Trop Med Public Health
;
1999 Sep; 30(3): 418-20
Article
in English
| IMSEAR
| ID: sea-32905
ABSTRACT
A cross sectional study was carried out in a rural area of Myanmar to identify malaria patients' acceptance of artesunate plus mefloquine drug combination and to determine the cost borne by patients. The majority (88.5%) preferred this new regimen rather than the other ones they had used before; conviction of drug efficacy was the reason given for the preference by most of them. Traveling on foot to rural health centers or a health assistant's residence for getting the drugs was found to be the main route. Average cost incurred by a patient to get the drug was found to be 274.22 Kyats. Among the cost items, drug cost was the highest item that they had used.
Full text:
Available
Index:
IMSEAR (South-East Asia)
Main subject:
Rural Population
/
Sesquiterpenes
/
Aged
/
Female
/
Humans
/
Male
/
Mefloquine
/
Cross-Sectional Studies
/
Adolescent
/
Patient Compliance
Type of study:
Observational study
/
Prevalence study
/
Risk factors
Country/Region as subject:
Asia
Language:
English
Journal:
Southeast Asian J Trop Med Public Health
Year:
1999
Type:
Article
Similar
MEDLINE
...
LILACS
LIS